Prof. Dr. med. Oliver Schnell

Lehrstuhl für Neurochirurgie

FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status (2012) Niyazi M, Schnell O, Suchorska B, Schwarz SB, Ganswindt U, Geisler J, Bartenstein P, et al. Journal article Personalized surgical therapy (2012) Tonn JC, Thon N, Schnell O, Kreth FW Journal article Near-infrared indocyanine green videoangiography (ICGVA) and intraoperative computed tomography (iCT): Are they complementary or competitive imaging techniques in aneurysm surgery? (2012) Schnell O, Morhard D, Holtmannspötter M, Reiser M, Tonn JC, Schichor C Journal article ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients (2012) Alexandra Adam S, Schnell O, Pöschl J, Eigenbrod S, Kretzschmar HA, Tonn JC, Schüller U Journal article Re-irradiation in recurrent malignant glioma: Prognostic value of [ 18F]FET-PET (2012) Niyazi M, Jansen N, Ganswindt U, Schwarz SB, Geisler J, Schnell O, Büsing K, et al. Journal article Molecular markers in low-grade gliomas: Predictive or prognostic? (2011) Hartmann C, Hentschel B, Tatagiba M, Schramm J, Schnell O, Seidel C, Stein R, et al. Journal article Intraoperative computed tomography. (2011) Tonn JC, Schichor C, Schnell O, Zausinger S, Uhl E, Morhard D, Reiser M Journal article FET-PET for malignant glioma treatment planning (2011) Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, et al. Journal article Presence of pluripotent CD133+ cells correlates with malignancy of gliomas (2010) Thon N, Damianoff K, Hegermann J, Grau S, Krebs B, Schnell O, Tonn JC, Goldbrunner R Journal article Unmet medical needs in glioblastoma management and optimal sequencing of the emerging treatment options (2010) Schnell O, Tonn JC Journal article, Review article